NHS reference costs: a history and cautionary note.
Journal article
Amies-Cull B. et al, (2023), Health Econ Rev, 13
Projected health and economic impacts of sugar-sweetened beverage taxation in Germany: A cross-validation modelling study.
Journal article
Emmert-Fees KMF. et al, (2023), PLoS Med, 20
Estimating the health impacts of sugar-sweetened beverage tax for informing policy decisions about the obesity burden in Vietnam
Journal article
Nguyen DT. et al, (2023), PLoS ONE, 18
Weight regain after behavioural weight management programmes and its impact on quality of life and cost effectiveness: Evidence synthesis and health economic analyses
Journal article
Hartmann-Boyce J. et al, (2023), Diabetes, Obesity and Metabolism, 25, 526 - 535
Estimating BMI distributions by age and sex for local authorities in England: A small area estimation study
Journal article
Amies-Cull B. et al, (2022), BMJ Open, 12
Sugar reduction—a bold contribution to addressing preventable illness
Journal article
Amies-Cull B., (2022), BMJ: British Medical Journal
Small area estimates of BMI by age, sex and lower tier local authority (England)
Dataset
Amies-Cull B. et al, (2022)
Dataset: Small area estimates of BMI distribution by age, sex and lower tier local authority (England)
Dataset
Amies-Cull B. et al, (2022)
Estimating the potential impacts of the Public Health England Sugar Reduction Strategy on child and adult health: a modelling study
Journal article
Amies-Cull B. et al, (2019), BMJ
Estimating the potential impact of the UK government's sugar reduction programme on child and adult health: Modelling study
Journal article
Amies-Cull B. et al, (2019), BMJ (Online), 365
General practice should hold government to account on disease prevention
Journal article
Amies B., (2017), British Journal of General Practice, 67
THE EFFECTS OF THE 2007-9 FINANCIAL CRISIS ON MENTAL HEALTH IN THE UK: A LONGITUDINAL ANALYSIS OF NON-SUICIDE MENTAL HEALTH TRENDS
Conference paper
Amies B. et al, (2017), JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 71, A32 - A32
FACTORS INFLUENCING MORTALITY IN IPF PATIENTS TREATED WITH PIRFENIDONE
Conference paper
Frank R. et al, (2012), THORAX, 67, A121 - A121
QUALITY OF LIFE AND ADVERSE EFFECTS IN PATIENTS TAKING PIRFENIDONE FOR IDIOPATHIC PULMONARY FIBROSIS
Conference paper
Capps J. et al, (2012), THORAX, 67, A120 - A120